Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-03 Sale | 2025-09-04 4:53 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 12 | $6.78 | $81 | 9,463 (Direct) | View |
| 2025-07-29 Sale | 2025-07-30 4:56 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 191 | $4.37 | $835 | 27,223 (Direct) | View |
| 2025-07-22 Sale | 2025-07-23 5:18 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 238 | $4 | $952 | 9,475 (Direct) | View |
| 2025-05-06 Sale | 2025-05-07 5:03 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 236 | $7.12 | $1,680 | 82,503 (Direct) | View |
| 2025-04-23 Sale | 2025-04-24 4:40 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 419 | $6.17 | $2,585 | 28,853 (Direct) | View |
| 2025-04-04 Sale | 2025-04-07 4:59 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 245 | $3.74 | $916 | 82,739 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:27 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 3,445 | $6.29 | $21,669 | 34,314 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:27 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 11,694 | $6.29 | $73,555 | 82,984 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:26 pm | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 3,587 | $6.29 | $22,562 | 29,272 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:24 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 3,548 | $6.29 | $22,317 | 27,414 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:15 pm | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 571 | $6.29 | $3,592 | 9,713 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:13 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 2,793 | $6.29 | $17,568 | 21,047 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 4:17 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 5,914 | $0.63 | $3,726 | 320,714 (Direct) | View |
| 2025-02-04 Sale | 2025-02-05 4:16 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 4,099 | $0.65 | $2,664 | 1,120,158 (Direct) | View |
| 2025-01-06 Sale | 2025-01-07 4:03 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 4,055 | $0.783 | $3,175 | 1,124,257 (Direct) | View |
| 2024-12-04 Sale | 2024-12-05 4:15 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,620 | $0.81 | $2,932 | 1,128,312 (Direct) | View |
| 2024-11-05 Sale | 2024-11-06 4:06 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,675 | $0.9106 | $3,346 | 1,131,932 (Direct) | View |
| 2024-10-04 Sale | 2024-10-07 4:44 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,607 | $0.8793 | $3,172 | 1,135,607 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 4:28 pm | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 3,971 | $0.7218 | $2,866 | 273,881 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 4:26 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,667 | $0.7218 | $2,647 | 1,139,214 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 4:24 pm | Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer | 7,050 | $0.7218 | $5,089 | 391,054 (Direct) | View |
| 2024-09-04 Sale | 2024-09-05 4:13 pm | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 5,356 | $0.7218 | $3,866 | 404,051 (Direct) | View |
| 2024-08-06 Sale | 2024-08-08 4:31 pm | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 3,608 | $0.9299 | $3,355 | 1,142,881 (Direct) | View |
| 2024-07-30 Sale | 2024-07-31 4:14 pm | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 2,883 | $1.06 | $3,056 | 326,628 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-28 Option Award | 2025-05-29 4:15 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Su Zhen Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:13 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:12 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Oliger Christy J. Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:09 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:08 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:07 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-05-28 Option Award | 2025-05-29 4:05 pm | N/A 2035-05-27 | Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director | 4,600 | $0 | 4,600 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:54 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer | 29,998 | $0 | 57,758 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:52 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer | 29,998 | $0 | 52,858 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:51 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer | 28,749 | $0 | 50,128 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:49 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 2,799 | $0 | 12,150 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:48 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO | 60,000 | $0 | 134,678 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-04 4:46 pm | N/A 2035-02-27 | Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary | 16,749 | $0 | 35,006 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-03 4:15 pm | N/A 2035-01-30 | Karyopharm Therapeutics Inc. | KPTI | Macomber Lori EVP, CFO & Treasurer | 810,000 | $0 | 810,000 (Direct) | View |
Ownership | 2024-11-22 4:01 pm | N/A N/A | Karyopharm Therapeutics Inc. | KPTI | Abate Kristin Chief Accounting Officer | 0 | $0 | 140,300 (Direct) | View |